FIELD: medicine. SUBSTANCE: method involves per os administering type 1 interferons, each time is carried out at a dose of 50 to 2500 MU/kg. Disseminated sclerosis is treated for reducing severity degree or recurrence frequency as well as to reduce autoimmune inflammation and inhibiting autoimmune disease attacks. EFFECT: enhanced effectiveness of treatment. 14 cl, 10 dwg
| Title | Year | Author | Number |
|---|---|---|---|
| APPLICATION OF 5'-METHYLTHIOADENOSINE (MTA) FOR PREVENTION AND/OR TREATMENT OF AUTOIMMUNE DISEASES AND/OR GRAFT REJECTION | 2005 |
|
RU2393866C2 |
| COMPOSITION FOR EFFECT ON TUMOR CELLS | 1991 |
|
RU2114633C1 |
| CONJUGATE OF ANTIMELANOMA ANTIBODY AND CYTOTOXIC AGENT AND A METHOD OF MELANOMA INHIBITION | 1991 |
|
RU2119352C1 |
| ONCOINHIBIN, METHOD OF ITS PREPARING AND ONCOINHIBIN-CONTAINING PHARMACEUTICAL COMPOSITION | 1993 |
|
RU2139087C1 |
| MAIN FATTY ACID ETHERS AND THEIR APPLICATION AS ANTI-INFLAMMATION OR IMMUNOMODULATORY MEDICATIONS | 2003 |
|
RU2337093C2 |
| COMPOSITION SHOWING CYTOTOXIC EFFECT, A METHOD OF TREATMENT OF LEUKEMIC CELL IN VITRO | 1993 |
|
RU2127122C1 |
| COMPOSITIONS AND METHODS OF TREATING NEUROLOGICAL DISTURBANCES | 2005 |
|
RU2387453C2 |
| COMPOSITION AND METHOD OF AUTOIMMUNE DISEASES TREATMENT | 2012 |
|
RU2621129C2 |
| COP1 FOR TREATMENT OF INFLAMMATORY DISEASES OF INTESTINE | 2004 |
|
RU2339397C2 |
| COMPOUNDS AND PHARMACEUTIC COMBINATIONS FOR TREATMENT OF NEURODEGENERATIVE AND ISCHEMIC BRAIN DISEASES | 2012 |
|
RU2569302C2 |
